Compare Repligen Corporation Common Stock (RGEN) vs Suncor Energy Inc. (SU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs Suncor Energy Inc. — how do they compare? Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B), while Suncor Energy Inc. trades at $75.96 (market cap $87.48B). The key difference: Suncor Energy Inc. is far larger — about 7.9× Repligen Corporation Common Stock's market cap, and Suncor Energy Inc. pays a 2.26% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Suncor Energy Inc. for 57 Days on average.
| RGEN | SU | |
|---|---|---|
Market Cap | $11.14B | $87.48B |
Volume | 1,259,263 | 3,692,639 |
Sector | Health | Energy |
52-Week High | $194.57 | $75.89 |
52-Week Low | $102.87 | $38.17 |
Typical Hold Time | 0 Days | 57 Days |
Enterprise Value | $11.02B | $94.00B |
Dividend Yield | — | 2.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Suncor Energy (SU) trades at $75.2, up 2.3% today, near its recent highs. The stock shows strong technical momentum with bullish moving averages, though RSI levels suggest potential overbought conditions. Fundamentally, SU maintains solid profitability with a 14.7% net income margin and trades at a reasonable P/E of 14.32. Recent news highlights asset sales and shareholder returns, while analyst sentiment is overwhelmingly positive with 74% buy ratings.
Outlook: SU's integrated model and aggressive buybacks support upside, but reliance on commodity prices and operational risks pose challenges. The stock offers value with growth potential, yet investors should monitor oil price volatility and execution of strategic initiatives for sustained performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →
